| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | 0.0046 | 1 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | 0.0025 | 1 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |